Investigating the influence of baseline medications on immune checkpoint inhibitor treatment outcomes for cancer patients 3706
Samantha Stone, Zaki F. Wilmot, Zoe Quandt, Aik Choon Tan et autres
Abstract Description Immune checkpoint inhibitors (ICIs) are first-line treatment options for many cancer patients. However, ICI treatment resistance and risk of immune-mediated toxicities continue to impact therapeutic success. Concomitant medications are increasingly recognized for their immunomodulatory properties, yet interactions within complex cancer …
us (code pays fourni par la source)